Khadka A, Subedi S, Lama N, Bhattarai I, Deuba C, Khatri U
Clin Case Rep. 2025; 13(3):e70303.
PMID: 40062310
PMC: 11888929.
DOI: 10.1002/ccr3.70303.
Santos A, Brito M, Oliveira A, Davila R, Gama H, Silva E
Malar J. 2024; 23(1):399.
PMID: 39716245
PMC: 11667890.
DOI: 10.1186/s12936-024-05209-1.
Abla N, Marrast A, Jambert E, Richardson N, Duparc S, Almond L
Malar J. 2024; 23(1):287.
PMID: 39334094
PMC: 11438061.
DOI: 10.1186/s12936-024-05112-9.
Santos A, Brito M, Silva E, Rocha F, Oliveira A, Davila R
PLoS Negl Trop Dis. 2024; 18(6):e0012197.
PMID: 38837977
PMC: 11152287.
DOI: 10.1371/journal.pntd.0012197.
Sharma R, Sharma H, Jones S, Borghini-Fuhrer I, Domingo G, Gibson R
Malar J. 2024; 23(1):145.
PMID: 38741094
PMC: 11092214.
DOI: 10.1186/s12936-024-04924-z.
Associations between COVID-19 and Glucose-6-Phosphate Dehydrogenase Activity in Brazil.
de Almeida Rodrigues M, Monteiro W, Cardoso de Melo G, Dias A, Sartim M, Xavier M
Am J Trop Med Hyg. 2024; 110(6):1191-1197.
PMID: 38593787
PMC: 11154054.
DOI: 10.4269/ajtmh.23-0148.
Operational feasibility of Plasmodium vivax radical cure with tafenoquine or primaquine following point-of-care, quantitative glucose-6-phosphate dehydrogenase testing in the Brazilian Amazon: a real-life retrospective analysis.
Brito M, Rufatto R, Murta F, Sampaio V, Balieiro P, Baia-Silva D
Lancet Glob Health. 2024; 12(3):e467-e477.
PMID: 38365417
PMC: 10882209.
DOI: 10.1016/S2214-109X(23)00542-9.
Tafenoquine following G6PD screening versus primaquine for the treatment of vivax malaria in Brazil: A cost-effectiveness analysis using a transmission model.
Price D, Nekkab N, Monteiro W, Villela D, Simpson J, Lacerda M
PLoS Med. 2024; 21(1):e1004255.
PMID: 38194420
PMC: 10775976.
DOI: 10.1371/journal.pmed.1004255.
Severe Hemolysis during Primaquine Radical Cure of Plasmodium vivax Malaria: Two Systematic Reviews and Individual Patient Data Descriptive Analyses.
Yilma D, Groves E, Brito-Sousa J, Monteiro W, Chu C, Thriemer K
Am J Trop Med Hyg. 2023; 109(4):761-769.
PMID: 37604475
PMC: 10551063.
DOI: 10.4269/ajtmh.23-0280.
Association of and Genetic Variants on Primaquine Hemolysis in G6PD-Deficient Patients.
Macedo M, Almeida A, Silva G, Oliveira A, Mwangi V, Shuan A
Pathogens. 2023; 12(7).
PMID: 37513742
PMC: 10384057.
DOI: 10.3390/pathogens12070895.
Association of G6PD status and haemolytic anaemia in patients receiving anti-malarial agents: a systematic review and meta-analysis.
Nelwan E, Shakinah S, Pasaribu A
Malar J. 2023; 22(1):77.
PMID: 36872344
PMC: 9985861.
DOI: 10.1186/s12936-023-04493-7.
Ancestry, diversity, and genetics of health-related traits in African-derived communities (quilombos) from Brazil.
Joerin-Luque I, Sukow N, Bucco I, Tessaro J, Gusmao Lopes C, Barbosa A
Funct Integr Genomics. 2023; 23(1):74.
PMID: 36867305
PMC: 9982798.
DOI: 10.1007/s10142-023-00999-0.
Prevalence of glucose 6-phosphate dehydrogenase deficiency in highly malaria-endemic municipalities in the Brazilian Amazon: A region-wide screening study.
Nascimento J, Brito-Sousa J, Almeida A, Melo M, Costa M, Barbosa L
Lancet Reg Health Am. 2023; 12:100273.
PMID: 36776424
PMC: 9903920.
DOI: 10.1016/j.lana.2022.100273.
Potential Benefits of Lycopene Consumption: Rationale for Using It as an Adjuvant Treatment for Malaria Patients and in Several Diseases.
Varela E, Gomes A, Santos A, de Carvalho E, Vale V, Percario S
Nutrients. 2022; 14(24).
PMID: 36558462
PMC: 9787606.
DOI: 10.3390/nu14245303.
Quantitative G6PD Deficiency Screening in Routine Malaria Diagnostic Units in the Brazilian Amazon (SAFEPRIM): An Operational Mixed-Methods Study.
Brito-Sousa J, Murta F, Vitor-Silva S, Sampaio V, Mendes M, Souza B
Pathogens. 2022; 11(11).
PMID: 36422580
PMC: 9696723.
DOI: 10.3390/pathogens11111328.
Potential of nanoformulations in malaria treatment.
Chaves J, de Moraes B, Ferrarini S, da Fonseca F, Silva A, Goncalves-de-Albuquerque C
Front Pharmacol. 2022; 13:999300.
PMID: 36386185
PMC: 9645116.
DOI: 10.3389/fphar.2022.999300.
G6PD testing and radical cure for Plasmodium vivax in Cambodia: A mixed methods implementation study.
Kheang S, Ridley R, Ngeth E, Ir P, Ngor P, Sovannaroth S
PLoS One. 2022; 17(10):e0275822.
PMID: 36264996
PMC: 9584508.
DOI: 10.1371/journal.pone.0275822.
Risk of hemolysis in Plasmodium vivax malaria patients receiving standard primaquine treatment in a population with high prevalence of G6PD deficiency.
Liu H, Zeng W, Malla P, Wang C, Lakshmi S, Kim K
Infection. 2022; 51(1):213-222.
PMID: 35976559
PMC: 9892342.
DOI: 10.1007/s15010-022-01905-9.
A PCR-RFLP Technique to Assess the Geographic Origin of Strains in Central America.
Fontecha G, Escobar D, Ortiz B, Pinto A
Trop Med Infect Dis. 2022; 7(8).
PMID: 35893657
PMC: 9394469.
DOI: 10.3390/tropicalmed7080149.
Effect of weekly versus daily primaquine on Plasmodium vivax malaria recurrences: A real-life cohort study.
Brito-Sousa J, Phanor J, Balieiro P, Silva-Neto A, Cordeiro J, Vitor-Silva S
Rev Soc Bras Med Trop. 2022; 55:e07382021.
PMID: 35522815
PMC: 9070075.
DOI: 10.1590/0037-8682-0738-2021.
